Single Center Experience Study with Pembrolizumab in Patients with BRAF Mutant Negative Metastatic Melanoma
Journal Title: Acta Facultatis Medicae Naissensis - Year 2018, Vol 34, Issue 4
Abstract
The aim of the paper was to determine the efficacy, toxicity and progression free survival with anti-PD-1 immunotherapy pembrolizumab in BRAF wild type metastatic melanoma patients with good performance status (ECOG PS 0–1). From February 2017 to April 2018, 17 patients with BRAF mutant wild type metastatic melanoma were enrolled in the study. Only 3/17 patient had received chemotherapy previously. The aim of the study was to confirm the efficacy of pembrolizumab immunotherapy in patients with good performance status (ECOG 0-1). Treatment consisted of pembrolizumab 2 mg/kg Q3 weeks continued until disease progression or intolerable toxicity. Secondary end points included toxicity and progression-free survival (defined as the time from randomization to documented disease progression according to RECIST). The overall response rate (ORR) was 11/17 (53.0 %), with complete response (CR) 0, partial response (PR) 3 (18 %), stable disease (SD) 8 (47%), and progressive disease (PD) 6 (35%). A total number of 97 consecutive cycles were administered. Adverse effects were mild. The most common toxicity was pneumonitis grade 1. None of the patients in the study demonstrated grade 2, 3 and 4 toxicity. No treatment-related deaths occurred. The median time to disease progression was 5.8 months. Anti-PD-1 pembrolizumab immunotherapy appeared to be a beneficial therapeutic approach with less toxicity for metastatic BRAF wild type melanoma patients with good PS.
Authors and Affiliations
Ivica Pejčić, Ivan Petković, Ana Cvetanović, Irena Conić
Keywords
Related Articles
- EP ID EP422394
- DOI 10.2478/afmnai-2018-0028
- Views 99
- Downloads 0
PRIMENA MINI DENTALNIH IMPLANTATA I ILIJAČNOG GRAFTA U REHABILITACIJI ATROFIČNE DONJE VILICE: PRIKAZ SLUČAJA
Atrofija donje vilice je progresivan proces, pa vremenom, sposobnost da se održe funkcije žvakanja i govora može biti značajno ugrožena, naročito zbog smanjenja potpornog tkiva. Cilj rada je da prikaže protetsku rehablit...
FRONTAL RECESS MUCOCELE ASSOCIATED WITH OSTEOMA: CASE REPORT
The paranasal sinus mucocele is an epithelized cystic lesion containing fluid and is characterized by non-neoplastic expansion of the paranasal sinus due to its capacity to erode the overlying bone. Etiology of these les...
Implantable Loop Recorder – A Good Opportunity to Diagnose Unexplained Syncope
Implantable loop recorder (ILR) is a method in cardiology, which is used for the diagnosis of unexplained syncope in patients who were not treated successfully using standard methods. Implantable loop recorder is a diagn...
MEDICATION ADHERENCE IN OUTPATIENTS WITH ARTERIAL HYPERTENSION
The degree of patient cooperation plays a key role in the success of antihypertensive drug therapy. Non-adherence is the major health and economic problem in the treatment of arterial hypertension (HTA). The aim of the s...
Correlation between Biochemical and Morphometric Parameters in Gentamicin-Induced Kidney Injury: The Role of Co-Supplementation with Vitamins C and E
The purpose of our study was to determine the effects of co-treatment with vitamins C and E on gentamicin-induced nephrotoxicity and to quantify renal structural changes through morphometric analysis. Experiments were do...